Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults
Journal of Clinical Oncology · 20.02.2024 · 42 (6) · 630-641
DOI: 10.1200/jco.23.01367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.02.2024. Verfasst von Theresa H M Keegan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Center for Oncology Hematology Outcomes Research and Training (COHORT), University of California Davis Comprehen…. Hauptthemen laut MEDLINE: Neoplasms, Survival Rate. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Although data from 1975 to 1997 revealed a gap in cancer survival improvement in adolescents and young adults (AYAs; 15-39 years) compared with children and older adults, more recent studies have reported improvements in AYA cancer survival overall. The current analysis provides an update of 5-year relative survival and cancer survival trends among AYAs compared with children and older adults. METHODS We obtained data from the National Cancer Institute Surveillance, Epidemiology, and End Results Program for 17 regions to obtain recent (2010-2018) 5-year relative survival estimates by cancer type, stage, sex, and race/ethnicity by age group. In addition, we calculated 5-year relative survival trends during 2000-2014. RESULTS Across 33 common AYA cancers, AYAs and children had high 5-year relative survival (86%) and experienced similar survival improvements over time (average absolute change: AYAs, 0.33%; children 0.36%). Among AYAs, 73% of cancers had improvement in 5-year relative survival since 2000. Despite this overall progress, we identified cancers where survival was worse in AYAs than younger or older patients and cancers that have had either a lack of improvement (osteosarcoma and male breast) or decreases in survival (cervical and female bladder) over time. Furthermore, males had inferior survival to females for all cancers, except Kaposi sarcoma and bladder cancer, and non-Hispanic Black/African American AYAs experienced worse survival than other racial/ethnic groups for many cancers considered in this study. CONCLUSION Future studies should focus on identifying factors affecting survival disparities by age, sex, and race/ethnicity. Differences in biology, clinical trial enrollment, delivery of treatment according to clinical guidelines, and supportive and long-term survivorship care may account for the survival disparities we observed and warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hematology and Oncology, Center for Oncology Hematology Outcomes Research and Training (COHORT), University of California Davis Comprehensive Cancer Center, Sacramento, CA.
- Division of Pediatric Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA.
ORCID-Profile: Theresa H M Keegan, Renata Abrahão, Elysia M Alvarez
Förderung
- NCI NIH HHS
Zitieren
APA
Keegan, T. H. M., Abrahão, R., & Alvarez, E. M. (2024). Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults. Journal of Clinical Oncology, 42(6), 630-641. https://doi.org/10.1200/jco.23.01367
Vancouver
Keegan THM, Abrahão R, Alvarez EM. Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults. Journal of Clinical Oncology. 2024;42(6):630-641. doi:10.1200/jco.23.01367
BibTeX
@article{Keegan2024,
author = {Keegan, Theresa H M and Abrahão, Renata and Alvarez, Elysia M},
title = {Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {6},
pages = {630--641},
doi = {10.1200/jco.23.01367}
}
EUVIMED